3 insiders reported 10 Form 4 transactions for Ascendis Pharma A/S (ASND) over the past 18 months (most recent 2026-08-18). Recent activity: BIENAIME JEAN JACQUES (Director) Buy 900 shares, BIENAIME JEAN JACQUES (Director) Buy 1,100 shares, SMITH SCOTT THOMAS (EVP & Chief Financial Officer) Buy 100 shares, BIENAIME JEAN JACQUES (Director) Buy 200 shares, SMITH SCOTT THOMAS (EVP & Chief Financial Officer) Buy 250 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-18 | BIENAIME JEAN JACQUES | Director | Buy | 900 | $222,219 |
| 2026-08-18 | BIENAIME JEAN JACQUES | Director | Buy | 1,100 | $270,435 |
| 2026-06-02 | SMITH SCOTT THOMAS | EVP & Chief Financial Officer | Buy | 100 | $21,900 |
| 2026-06-01 | BIENAIME JEAN JACQUES | Director | Buy | 200 | $44,752 |
| 2026-06-01 | SMITH SCOTT THOMAS | EVP & Chief Financial Officer | Buy | 250 | $55,830 |
| 2026-06-01 | BIENAIME JEAN JACQUES | Director | Buy | 200 | $44,460 |
| 2026-06-01 | BIENAIME JEAN JACQUES | Director | Buy | 100 | $22,350 |
| 2026-05-27 | BIENAIME JEAN JACQUES | Director | Buy | 200 | $47,874 |
| 2026-05-27 | BIENAIME JEAN JACQUES | Director | Buy | 200 | $47,247 |
| 2026-05-12 | JENSEN FLEMMING STEEN | See Remarks | Sell | 19,460 | $4.6M |
Source: SEC Form 4 filings · as of 2026-08-18